{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T10:12:08Z","timestamp":1698833528178},"reference-count":25,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T00:00:00Z","timestamp":1344902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Artificial Organs"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Among the different potential mechanisms that could lead to brain edema and intracranial hypertension in fulminant hepatic failure (FHF), the inflammatory hypothesis implies that systemic inflammation might be in part responsible for an increase in cerebral blood flow (CBF) and brain water content. In this study, the authors used a validated ischemic FHF swine model to evaluate the effects of 80\u2003kDa large\u2010pore membrane hemofiltration (LPHF) on intracranial pressure (ICP) and CBF, in relation with the clearance of proinflammatory cytokines and blood liver tests, as primary end points. Fifteen pigs were randomized into one of three groups: SHAM, FHF, and FHF\u2003+\u2003LPHF. All experiments lasted 6\u2003h. In the FHF groups, liver failure was induced by liver ischemia. After 2\u2003h, the FHF\u2003+\u2003LPHF group underwent 4\u2003h of a zero\u2010balance continuous veno\u2010venous hemofiltration using a 0.7\u2010m<jats:sup>2<\/jats:sup>, large\u2010pore (78\u2003\u00c5) membrane with a cutoff of 80\u2003kDa. ICP, CBF, mean arterial pressure, central venous pressure, and heart rate were continuously monitored and recorded. Arterial aspartate aminotransferase, total bilirubin, creatinine, international normalized ratio, glucose, lactate and serum cytokines interleukin (IL)\u20106, IL\u201010, and tumor necrosis factor\u2010\u03b1 were measured at T0, T120, and T360. Over the 6\u2003h following liver ischemia, the FHF group developed a significant increase in ICP. This ICP rise was not observed in the SHAM group and was attenuated in the FHF\u2003+\u2003LDHF group. However, the ICP levels were not different at T360 in the FHF\u2003+\u2003LDHF group compared to the FHF group. No significant effect of LPHF on liver tests or levels of proinflammatory cytokines could be demonstrated. In this model, 80\u2003kDa LPHF was not efficient to control FHF intracranial hypertension and to decrease serum cytokine levels.<\/jats:p>","DOI":"10.1111\/j.1525-1594.2012.01506.x","type":"journal-article","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T08:17:14Z","timestamp":1344932234000},"page":"981-987","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Large\u2010Pore Hemofiltration in a Swine Model of Fulminant Hepatic Failure"],"prefix":"10.1111","volume":"36","author":[{"given":"Olivier","family":"Detry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Paul","family":"Cheramy\u2010Bien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Olivier","family":"Defraigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Delanaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Lambermont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,14]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2005.04.010"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i9.1427"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/00015458.1998.12098423","article-title":"Management of fulminant hepatic failure","volume":"98","author":"Detry O","year":"1998","journal-title":"Acta Chir Belg"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199903150-00024"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i46.7405"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.010"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00240-4"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889802101201"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199405000-00012"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/000313489906501008","article-title":"Clinical use of a bioartificial liver in the treatment of acetaminophen\u2010induced fulminant hepatic failure","volume":"65","author":"Detry O","year":"1999","journal-title":"Am Surg"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000124298.74199.e5"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000196203.39832.3C"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000191127.67254.14"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2006.00355.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.2006.00260.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139880602901004"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24228"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc5143"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2011.07.014"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00003-4"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.07.103"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc5119"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21930"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.05.061"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000208790"}],"container-title":["Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1594.2012.01506.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1594.2012.01506.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:02:19Z","timestamp":1698778939000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1594.2012.01506.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,14]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1111\/j.1525-1594.2012.01506.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1594.2012.01506.x","archive":["Portico"],"relation":{},"ISSN":["0160-564X","1525-1594"],"issn-type":[{"value":"0160-564X","type":"print"},{"value":"1525-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,14]]}}}